PT Multi Medika Internasional Tbk (ISX:MMIX) Research & Development: Rp Mil (TTM As of Dec. 2021)


ISX:MMIX PT Multi Medika Internasional Tbk ISX:MMIX
24 GF Score
Price Rp750.00
View Full Analysis

What is PT Multi Medika Internasional Tbk Research & Development?

PT Multi Medika Internasional Tbk ISX:MMIX -4.46% 24 Research & Development is Rp Mil as of Dec. 2021. GuruFocus rates ISX:MMIX with a GF Score™ of 24/100.

Research & Development is the aggregate amount of research and development expenses during the year. PT Multi Medika Internasional Tbk's Research & Development for the six months ended in Dec. 2021 was Rp0 Mil. PT Multi Medika Internasional Tbk does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in Dec. 2021.

PT Multi Medika Internasional Tbk  (ISX:MMIX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PT Multi Medika Internasional Tbk Research & Development Related Terms

PT Multi Medika Internasional Tbk Research & Development Historical Data

* Premium members only.

The historical data trend for PT Multi Medika Internasional Tbk's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Multi Medika Internasional Tbk Research & Development Chart

PT Multi Medika Internasional Tbk Annual Data
Trend Dec20 Dec21
Research & Development
0.00 0.00

PT Multi Medika Internasional Tbk Semi-Annual Data
Dec20 Dec21
Research & Development 0.00 0.00
ISX:MMIX
24GF Score
PT Multi Medika Internasional Tbk ISX:MMIX
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Multi Medika Internasional Tbk Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of Rp Mil mean?
PT Multi Medika Internasional Tbk (ISX:MMIX) has a Research & Development of Rp Mil as of Dec. 2021. Research and development expense is the total cost for research and development activities. View historical data on PT Multi Medika Internasional Tbk and its competitors.
Is PT Multi Medika Internasional Tbk's Research & Development too high?
PT Multi Medika Internasional Tbk's current Research & Development is Rp Mil. Overall, PT Multi Medika Internasional Tbk has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does PT Multi Medika Internasional Tbk's Research & Development compare to competitors?
PT Multi Medika Internasional Tbk's Research & Development of Rp Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on PT Multi Medika Internasional Tbk and its competitors. PT Multi Medika Internasional Tbk's current Research & Development is Rp Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Multi Medika Internasional Tbk stock overvalued right now?
PT Multi Medika Internasional Tbk (ISX:MMIX) has a current Research & Development of Rp Mil. The current Research & Development is Rp Mil. PT Multi Medika Internasional Tbk's overall GF Score™ is 24/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For PT Multi Medika Internasional Tbk (ISX:MMIX), the current Research & Development is Rp Mil as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Multi Medika Internasional Tbk Business Description

Address Jl. Peternakan III No.55B, Kelurahan Kapuk, Kecamatan Cengkareng, Jakarta Barat, DKI Jakarta, Kode Pos, Jakarta, IDN, 11720
PT Multi Medika Internasional Tbk is engaged in the wholesale trading of medical devices and pharmaceutical and laboratory equipment for humans, operating lease, and non-copyrighted works. It also wholesales other food and beverages, such as rice flour, tapioca flour, bakery premix, caramel, processed honey, shrimp crackers and others; agricultural food and beverages, such as herbs and spices; livestock and fisheries; non-alcoholic beverages, such as fruit juice, soft drinks, mineral water, bottled water, and other similar products; cosmetics for humans such as perfume, soap, powder and others. Its segments include Mask and other non food and beverages, and food and beverages. It derives the majoritf of the revenue from Mask and other non food and beverages segments.
24GF Score

Get the complete analysis for ISX:MMIX

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp750.00
Price